Piergiorgio Pettazzoni is an accomplished scientist specializing in oncology, currently serving as Group Head and Senior Principal Scientist at Roche since November 2015, where leadership focuses on oncology drug discovery from hypothesis generation to clinical development. Prior experiences include roles as Principal Scientist, Senior Scientist, and Lab Head at MD Anderson Cancer Center, contributing to basic and translational research on pancreatic cancer and glioblastoma. Educational achievements include a PhD in Medicine and Experimental Oncology from Università degli Studi di Torino and a Master’s Degree in Molecular Biology. Additional research experience encompasses a Graduate Research Fellowship at Roswell Park Cancer Institute centered on prostate cancer.